Rigel Pharmaceuticals
RIGL
RIGL
167 hedge funds and large institutions have $426M invested in Rigel Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
18% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 45
6.05% more ownership
Funds ownership: 77.69% → 83.74% (+6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
167
Holding in Top 10
1
Calls
$2.45M
Puts
$1.9M
Top Buyers
| 1 | +$15.7M | |
| 2 | +$8.68M | |
| 3 | +$8.63M | |
| 4 |
Renaissance Technologies
New York
|
+$6.74M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$6.58M |
Top Sellers
| 1 | -$38.9M | |
| 2 | -$24.8M | |
| 3 | -$9.3M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$6.25M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$4.67M |
